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Abstract
Liver X and farnesoid X receptors (LXR and FXR, nomenclature as agreed by the NC-IUPHAR
Subcommittee on Nuclear Hormone Receptors [68]) are members of a steroid analogue-activated nuclear
receptor subfamily, which form heterodimers with members of the retinoid X receptor family. Endogenous
ligands for LXRs include hydroxycholesterols (OHC), while FXRs appear to be activated by bile acids. In
humans and primates, NR1H5P is a pseudogene. However, in other mammals, it encodes a functional nuclear
hormone receptor that appears to be involved in cholesterol biosynthesis [71].
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